Therefore, RAC2 is a novel and first identified target of NEDD4L in ccRCC, and the aberrant less expression of NEDD4L and consequent RAC2 upregulation may contribute to renal carcinogenesis. The gene discussed is NEDD4L; the disease is nonpapillary renal cell carcinoma.